Log In
Print
BCIQ
Print
Print this Print this
 

HIF1-alpha plasmid DNA therapy

  Manage Alerts
Collapse Summary General Information
Company Inovio Pharmaceuticals Inc.
DescriptionPlasmid DNA therapy that expresses hypoxia-inducible factor 1 alpha (HIF1A; HIF1-alpha)
Molecular Target Hypoxia-inducible factor 1 alpha (HIF1A) (HIF1-alpha)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationIschemia / reperfusion injury
Indication DetailsTreat critical limb ischemia (CLI)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today